CollPlant Biotechnologies Ltd.
CLGN | NASDAQ
$4.14
-$0.16 (-3.72%)
Sep 22, 2026, 2:43 PM ET · Market open
Market Data
Market Cap $5.58M
Enterprise Value $3.96M
Beta 0.74
Average Volume 161.42K
Shares Outstanding (Diluted) 1.37M
Shares Change YoY 20.02%
Institutional Ownership 0.00%
Exchange NASDAQ
ISIN IL0004960188
Price Performance
Price Change 1M 30.3%
Price Change 3M 22.2%
Price Change 6M -42.7%
Price Change YTD -71.0%
Price Change 1Y -82.7%
Price Change 3Y -92.8%
Price Change 5Y -97.4%
1M CAGR (ann.) 26.8%
1Y CAGR (ann.) -83.7%
5Y CAGR (ann.) -52.6%
All-Time CAGR N/A
Valuation
PE Ratio -0.42
Forward PE 140.00
PEG Ratio -0.03
Forward PEG 0.01
PS Ratio 14.33
Forward PS 2.20
PB Ratio 1.14
P/FCF Ratio -0.48
P/Adj. FCF Ratio -0.45
P/OCF Ratio -0.51
EV/Sales 10.19
EV/EBIT -0.31
EV/EBITDA -0.33
EV/FCF -0.34
Earnings Yield -239.5%
FCF Yield -208.1%
Adj. FCF Yield -222.8%
Financial Health
Net Cash $4.26M
Total Debt $2.65M
Cash & Short-Term Investments $4.26M
Total Assets $9.18M
Current Ratio 2.27
Quick Ratio 1.99
Debt / Equity Ratio 0.54
Debt / EBITDA -0.22
Debt / FCF -0.23
OCF / Debt -4.37
Interest Coverage -57.30
Altman Z-Score -22.92
Piotroski F-Score 1
Margins & Profitability
Gross Profit Margin -319.3%
Operating Profit Margin -3329.1%
EBITDA Margin -3092.6%
Net Profit Margin -3376.3%
FCF Margin -2982.6%
Adj. FCF Margin -3192.8%
SBC / Revenue 210.3%
SBC Impact (per share) -7.0%
Returns
Return on Assets -143.0%
Return on Equity -160.3%
Return on Invested Capital -171.9%
Return on Capital Employed -192.1%
Return on Tangible Assets -143.9%
Historical Growth (CAGR)
Revenue CAGR 3Y -16.4%
Revenue CAGR 5Y -54.5%
Revenue CAGR 10Y 2.6%
EPS CAGR 3Y -18.5%
EPS CAGR 5Y 7.4%
EPS CAGR 10Y 12.5%
FCF CAGR 3Y -44.5%
FCF CAGR 5Y 5.4%
FCF CAGR 10Y -14.0%
Analyst Forecasts
Analyst Rating Buy
Analyst Count 5
EPS Growth Next 3Y 28.5%
Revenue Growth Next 3Y 108.0%
Earnings Date Dec 1, 2026
EPS Estimate (next Q) -$0.24
EPS Growth Est (next Q) -90.9%
Revenue Est (next Q) $480K
Revenue Growth Est (next Q) 523.4%
Fair Value Estimates
Graham Number N/A
Graham Upside N/A
Lynch Fair Value N/A
Lynch Upside N/A
Price Target $12.50
Price Target Upside 190.7%
Cash Flow
Operating Cash Flow $-11.58M
Free Cash Flow $-11.6M
Adj. Free Cash Flow $-12.42M
FCF Per Share -$8.44
OCF Per Share -$8.42
OCF/S Ratio -2975.8%
Income Statement
Revenue $389K
Gross Profit $-1.24M
Operating Income $-12.95M
EBITDA $-12.03M
Net Income $-13.13M
EPS (Diluted) -$10.30
Revenue / Employee $9.97K
Profit / Employee $-336.77K
Employees 39
Add to Watchlist
Select watchlists to add or remove CLGN